Newsroom

Newsroom

Single-tube NGS profiling allows identification of molecular signature in ALL patients

Literature
Read More

NeoGenomics to Participate at the 22nd Annual Needham Virtual Healthcare Conference

Press Release
Read More

NeoGenomics to Share Nine Abstracts at the American Association of Cancer Research (AACR) Annual Meeting 2023

Press Release
Read More

NeoGenomics to Host Investor Day on April 4, 2023

Press Release
Read More

NeoGenomics Announces Commercial Availability of the RaDaR(R) Molecular Residual Disease Test

Press Release
Read More

NeoGenomics Expands NGS Portfolio with Launch of Neo Comprehensive(TM) - Solid Tumor CGP and Neo Comprehensive(TM) - Myeloid Disorders CGP

Press Release
Read More

NeoGenomics to Present at the 44th Annual Raymond James Institutional Investors Conference

Press Release
Read More

NeoGenomics Reports Fourth Quarter and Full Year 2022 Results

Press Release
Read More

Contact Us To Get Started!

Work with us – your premier oncology partner – to optimize cancer care for patients